Bicara Therapeutics Inc. ... (BCAX)
15.65
0.14 (0.90%)
At close: Apr 24, 2025, 3:59 PM
15.43
-1.44%
Pre-market: Apr 25, 2025, 07:10 AM EDT
Bicara Therapeutics Common Stock Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
33
Upside
110.80
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Wells Fargo | Sell | Initiates | 8 | -48.90% | Apr 17, 2025 | |
| HC Wainwright & Co. | Buy | Maintains | 45 44 | 181.06% | Apr 7, 2025 | |
| Cantor Fitzgerald | Buy | Initiates | 14 14 | -16.90% | Mar 13, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.